Information resources and records:
(Note: Public view documents are free to use and download under the Creative Commons Attribution- Non Commercial – ShareAlike license. Some resources are restricted to only Coordinators, Nerve Center Team, Advisory Group)
Latest additions: 1) Molecule Brief 31: Molnupiravir (Ver 8 Dec 2020), 2) Clinical Trials Update: Outcomes from Interventional Studies for Key Drugs Studied by TFORD (30 Nov 2020)
-
-
- Molecule Briefs
-
-
- Molecule Brief 1: Chloroquine (Ver 30 March 2020)
- Molecule Brief 2: Hydroxychloroquine (Ver 30 March 2020; Updated 5 April 2020)
- Molecule Brief 3: Remdesivir (Ver 30 March 2020)| Remdesivir (Updated June 2020)
- Molecule Brief 4: Lopinavir/Ritonavir (Ver 30 March 2020)
- Molecule Brief 5: Favipiravir (Ver 30 March 2020) | Favipiravir (Updated June 2020)
- Molecule Brief 6: Baloxavir Marboxil (Ver 30 March 2020)
- Molecule Brief 7: Darunavir (Ver 12 April 2020)
- Molecule Brief 8: Ribavarin + IFN-beta (Ver 12 April 2020)
- Molecule Brief 9: Galidesivir (Ver 12 April 2020)
- Molecule Brief 10: Oseltamivir (Ver 12 April 2020)
- Molecule Brief 11: Umifenovir (Ver 12 April 2020)
- Molecule Brief 12: Camostat mesylate (Ver 12 April 2020)
- Molecule Brief 13: Ruxolitinib (Ver 12 April 2020)
- Molecule Brief 14: IFN-beta (Ver 12 April 2020)
- Molecule Brief 15: Tocilizumab (Ver 12 April 2020)
- Molecule Brief 16: Ustekinumab (Ver 12 April 2020)
- Molecule Brief 17: Nigericin (Ver 12 April 2020)
- Molecule Brief 18: Teicoplanin (Ver 12 April 2020)
- Molecule Brief 19: Ivermectin (Ver 12 April 2020)
- Molecule Brief 20: Baricitinib (Ver 18 June 2020)
- Molecule Brief 21: Tofacitinib (Ver 18 June 2020)
- Molecule Brief 22: Dexamethasone (Ver 18 June 2020)
- Molecule Brief 23: Sarilumab (Ver 18 June 2020)
- Molecule Brief 24: Sepsivac (Ver 18 June 2020)
- Molecule Brief 25: Ulinastatin (Ver 18 June 2020)
- Molecule Brief 26: Nitazoxanide (Ver 18 June 2020)
- Molecule Brief 27: Enaxoparin (Ver 18 June 2020)
- Molecule Brief 28: Famotidine (Ver 18 June 2020)
- Molecule Brief 29: ACEi and ARB (Ver 18 June 2020)
- Molecule Brief 30: rhACE protein (Ver 18 June 2020)
- Molecule Brief 31: Molnupiravir (Ver 8 Dec 2020) NEW!!!
-
-
- Molecule Briefs
-
-
-
- Medicinal Herbs Brief
-
-
- Tinospora cordifolia (Ver 13 May 2020)
- Glycyrrhiza glabra (Ver 13 May 2020)
- Withania somnifera (Ver 13 May 2020)
- Zingiber officinale (Ver 13 May 2020)
- Andrographis paniculata (Ver 13 May 2020)
- Artemisia annua (Ver 13 May 2020)
- Cissampelos pareira (Ver 13 May 2020)
- Vitis vinifera (Ver 13 May 2020)
- Myrica cerifera (Ver 13 May 2020)
-
-
- Medicinal Herbs Brief
-
-
-
- Information trackers:
-
-
- Drug Monitor: We are tracking the latest information on key drug candidates for COVID19 (Credits: Dr Smita Kale) UPDATED!
- Clinical Trials (Interventional) in India (Credits: Dr Kirtee Wani)
-
-
- Update on 4 September 2020: Interventional CTs registered in India NEW!! NEW!!
- Update on 29 June 2020: Interventional CTs registered in India
- Update on 9 May 2020:
-
-
-
-
- Information trackers:
-
-
-
- Heat maps: See how our experts rate different molecules and the journey ahead:
-
-
- Heat map 1: Status of Drug Candidates and their Potential
-
-
- Update on 30 Nov 2020:
- Update on 1 Sep 2020:
- Update on 26 Apr 2020:
-
-
- Drug Candidate Readiness and Potential — Heat Map PDF document | Google Sheet (26 April 2020)
-
-
-
-
- Heat map 1: Status of Drug Candidates and their Potential
-
-
- Heat maps: See how our experts rate different molecules and the journey ahead:
-
-
-
-
-
- Heat map 2: Patent Position (Credits: Dr Vidula Walimbe & Gnanlex team)
-
-
- Update on 17 June 2020: Google Sheet UPDATED!
- Update on 26 April 2020
-
-
- Heat Map PDF document | Google Sheet
- Summary Chart for Patent Barriers (png | pdf)
- Summary Chart for Patent-related Need for GoI Action (png | pdf)
-
-
-
-
- Heat map 2: Patent Position (Credits: Dr Vidula Walimbe & Gnanlex team)
-
-
-
-
-
-
-
-
-
- Heat map 3: Clinical Trials Reported — Heat Map PDF document | Google Sheet (26 April 2020)
-
-
- Summary Chart for Clinical Trials with published results (pdf)
-
-
- Heat map 3: Clinical Trials Reported — Heat Map PDF document | Google Sheet (26 April 2020)
-
-
-
-
-
-
-
-
-
- Heat map 4: Indian manufacturers of drug candidates studied by TFORD
-
-
-
-
-
-
-
-
-
- Heat map 5: Selected medicinal herbs, status of CTs in India and selected major Indian manufacturers/ suppliers
-
-
-
-
-
-
- Assessment and categorisation frameworks
-
-
- Scientific evidence and technology de-risking
- Intellectual property (Ver 30 March 2020)
- Supply chain, manufacturing, financing
-
-
- Assessment and categorisation frameworks
-
- Funding options:
-
-
- USISTEF— COVID-19 Ignition Grants: 15 April – 15 May 2020
- SERB-CRG for COVID19: 2 -30 Apr 2020
- SERB-IRHPA for COVID19: 19 March – 30 April 2020
- DBT and BIRAC Funding Call (includes Repurposing of Drugs): 5 April – 15 May 2020
- BIRAC- BIPP funds trials: 15 Feb -30 April 2020
- BIRAC- ATGC (includes drugs): Ongoing
- CSIR-NMITLI “Breakthrough technology interventions against COVID19”: Till 5 April 2020
-
-
- Funding options:
-